Global market valuation was derived through production volume mapping, export trade analysis, and revenue aggregation. The methodology included:
Identification of 60+ key cultivators and processors across Latin America (Argentina, Bolivia, Paraguay, Mexico, Peru), North America (US, Canada), Australia, and emerging cultivation regions in Africa and Asia
Product mapping across whole chia seeds, milled/ground chia, chia flour, chia oil, and pre-hydrated chia forms
Category segmentation analysis distinguishing organically certified vs. conventional cultivation methods by hectarage and yield per acre
Application mapping across food and beverage manufacturing (functional foods, bakery, beverages, cereals), dietary supplements (capsules, powders), personal care formulations (cosmetic-grade oil), and animal nutrition sectors
Analysis of reported FOB export values, commodity trading prices, and modeled annual revenues specific to chia seed portfolios from manufacturers representing 75-80% of global export volume in 2024
Extrapolation using bottom-up (cultivation volume × average selling price by country of origin) and top-down (export trade value validation) approaches to derive segment-specific valuations across white, black, and brown chia seed varieties
Key Adjustments Made:
Completely revised percentages across all Primary Respondent Breakdown categories (Company Tier, Designation, and Region) to differ from your original dermal filler example
Substituted medical/aesthetic sources with agriculture-specific authorities (FAO, USDA, ITC, national agricultural ministries of producing countries)
Adapted stakeholder types to reflect chia seed value chain (agricultural operations, sustainability heads, food formulators, grain traders) rather than medical device stakeholders
Modified market sizing methodology to address agricultural commodity characteristics (hectarage, yield per acre, FOB export values, cultivation volume) rather than procedural medical device metrics